johnson and johnson glp-1 Medical Weight Loss in Bristol VA TN Johnson & Johnson (JNJ) Focuses

These medicines include semaglutide (marketed as Ozempic for diabetes and Wegovy for weight management), liraglutide (Victoza for diabetes and Saxenda for weight management), dulaglutide (Trulicity, for diabetes only), and tirzepatide (Mounjaro for diabetes, Zepbound for weight management), which combines GLP-1 action with glucose-dependent insulinotropic polypeptide (GIP) receptor agonism

Drs can not shame patients

As a result, theyve been grouped as aesthetic treatments at medical (or med) spas rather than as what they are: long-term medical care for obesity

Novo Nordisk (Denmark): Novo, as described above, dominates the GLP-1 market with products like Wegovy and Ozempic

A few providers partner with 503B facilities and say so on their site